Abstract:Approximately 3 years ago, we assessed how patient induced pluripotent stem cell (iPSC) research could potentially impact human pathobiology studies in the future. Since then, the field has grown considerably with numerous technical developments, and the idea of modeling diseases ‘in a dish’ is becoming increasingly popular in biomedical research. Likely, it is even acceptable to include patient iPSCs as one of the standard research tools for disease mechanism studies, just like knockout mice. However, as the field matures, we acknowledge there remain many practical limitations and obstacles for their genuine application to understand diseases, and accept that it has not been as straightforward to model disorders as initially proposed. A major practical challenge has been efficient direction of iPSC differentiation into desired lineages and preparation of the large numbers of specific cell types required for study. Another even larger obstacle is the limited value of in vitro outcomes, which often do not closely represent disease conditions. To overcome the latter issue, many new approaches are underway, including three-dimensional organoid cultures from iPSCs, xenotransplantation of human cells to animal models and in vitro interaction of multiple cell types derived from isogenic iPSCs. Here we summarize the areas where patient iPSC studies have provided truly valuable information beyond existing skepticism, discuss the desired technologies to overcome current limitations and include practical guidance for how to utilize the resources. Undoubtedly, these human patient cells are an asset for experimental pathology studies. The future rests on how wisely we use them.

Induced Pluripotent Stem Cells As a Disease Modeling and Drug Screening Platform

Inducing Pluripotency for Disease Modeling, Drug Development and Craniofacial Applications.

Human-Induced Pluripotent Stem Cell-Based Differentiation of Cardiomyocyte Subtypes for Drug Discovery and Cell Therapy

Human Induced Pluripotent Stem Cell for Modeling Cardiovascular Diseases.

Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling

Patient-Specific Induced Pluripotent Stem Cells for Disease Modeling and Phenotypic Drug Discovery

Drug screening for human genetic diseases using iPSC models

Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications

Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases

Pluripotent stem cells for neurodegenerative disease modeling: an expert view on their value to drug discovery

Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications

Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery

[Induced pluripotent stem cell technology and its application in disease research]

Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening

Induced Pluripotent Stem Cell Technology: A Paradigm Shift in Medical Science for Drug Screening and Disease Modeling

Best Practices for Translational Disease Modeling Using Human iPSC-Derived Neurons

Future Perspective of Induced Pluripotent Stem Cells for Diagnosis, Drug Screening and Treatment of Human Diseases.

A practical guide to induced pluripotent stem cell research using patient samples

iPSC Disease Modeling

Induced pluripotent stem cells for neural drug discovery

Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy